Nab-Paclitaxel Added To Gemcitabine And Epirubicin Shows Potential As Neoadjuvant Tre

[News]

SAN ANTONIO - NabTM-paclitaxel (Abraxane), used in tandem with gemcitabine and epirubicin, is showing good anti-tumor activity and tolerability as neoadjuvant treatment for women with locally advanced breast cancer, according to phase II results released at the 2008 San Antonio Breast Cancer Symposium (SABCS).

More... (http://www.medicalnewstoday.com/articles/133085.php)